$599

Early Wegovy Pill Prescription Trends; InterAx and Alveus Drug Discovery Partnership

Two cardiometabolic-related news items have been observed: Novo Nordisk tracks over 3,000 US prescriptions of Wegovy pill in the first four days of launch (view article); and InterAx and Alveus Therapeutics enter into a partnership for cardiometabolic drug discovery (view press release). Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here